CB2-MAX | MSWB | Edible Oil
BCP Infused Hemp Oil
CB2-MAX is hemp oil that’s been formulated to be infused with a legal dietary cannabinoid called BCP (β-Caryophyllene).
The Key Ingredients of CB₂-MAX
- Hemp Oil
- Canabene™ (β-Caryophyllene; BCP, d-Limonene, β-Myrcene, α- Pinene, β-Pinene, Linalool)
- Liquid Formula 11615™ (445, 433, 1521)
Directions For Use: Take 2mL twice daily mixed in water, milk, or juice by stirring vigorously, shaking, or blending.
KEEP OUT OF REACH OF CHILDREN. Not suitable for children under the age of 18 years. Do not use if you are pregnant or breastfeeding. If you are taking medications seek medical advice before consuming this product.
This product does not claim to the prevention, diagnosis, cure, or alleviation of a disease, disorder or condition, or represented in any way to be for therapeutic use or is likely to be taken to be for therapeutic use; whether because of the way in which the food is presented or for any other reason.
Complimentary Medical Association Approved Supplier for 2019
Silver Member of the International Alliance of Holistic Therapists for 2019
- Bahi, A. Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S. M. & Ojha, S. 2014. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiology & Behaviour, 135, pp. 119-124. DOI: 10.1016/j.physbeh.2014.06.003
- Basha, R. H. & Sankaranarayanan, C. 2014. β-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats. Acta Histochemica, 116(8), pp. 1469-1479. DOI: 10.1016/j.acthis.2014.10.001
- Bento, A. F., Marcon, R., Dutra, R. C., Claudino, R. F., Cola, M., Leite, D. F. & Calixto, J. B. 2011. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. The American Journal of Pathology, 178(3), pp. 1153-1166. DOI: 10.1016/j.ajpath.2010.11.052
- Calleja, M. A., Vieites, J. M., Montero-Meléndez, T., Torres, M. I., Faus, M. J., Gil, A. & Suárez, A. 2013. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. British Journal of Nutrition, 109(3), pp. 394-401. DOI: 10.1017/S0007114512001298
- Chang, H. J., Kim, J. M., Lee, J. C., Kim, W. K. & Chun, H. S. 2013. Protective effect of β-caryophyllene, a natural bicyclic sesquiterpene, against cerebral ischemic injury. Journal of Medical Food, 16(6), pp. 471-480. DOI: 10.1089/jmf.2012.2283
- Cheng, X. R., Zhou, W. X. & Zhang, Y. X. 2014. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer’s disease animal model. Ageing Research Reviews, 13, pp. 13-17. DOI: 10.1016/j.arr.2013.10.002
- Gertsch, J. 2008. Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action? Communicative & Integrative Biology, 1(1), pp. 26-28. DOI: 10.4161/cib.1.1.6568
- Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J. Z., Xie, X. Q., Altmann, K. H., Karsak, H. & Zimmer, A. 2008. Beta-caryophyllene is a dietary cannabinoid. PNAS, 105(26), pp. 9099-9104. DOI: 10.1073/pnas.0803601105
- Hartsel, J. A., Hades, J., Hickory, B. & Makriyannis, A. 2016. Chapter 53 – Cannabis sativa and Hemp. Nutraceuticals, 2016, pp. 735-754. DOI: 10.1016/B978-0-12- 802147-7.00053-X
- Mahmoud, M. F., Swefy, S. E., Hasan, R. A. & Ibrahim, A. 2014. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. European Journal of Pharmacology, 742, pp. 118-124. DOI: 10.1016/j.ejphar.2014.08.021
- Rufino, A. T., Ribeiro, M., Sousa, C., Judas, F., Salgueiro, L., Cavaleiro, C. & Mendes, A. F. 2015. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. European Journal of Pharmacology, 750, pp. 141-150. DOI: 10.1016/j.ejphar.2015.01.018